Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

How Stäubli and ARxIUM collaborated on pharma automation

By Sean Whooley | January 3, 2020

ARxIUM is collaborating with Stäubli for its TX-60L UL robot to enhance the effectiveness of pharmacy operations by improving the safety and accuracy of IV admixture compounding.

The collaboration particularly aids ARxIUM’s RIVA fully automated IV compounding system used by hospital pharmacies to prepare IV syringes and bags. It is designed to address safety for the patient and the pharmacy technician by automating the preparation process.

Stäubli’s TX-60L UL robot is designed to help move products from station to station through the RIVA compounding cell as each product is processed. When combined with the RIVA, Stäubli’s product offers quick movement and allows users the flexibility to run single daily shifts, compared to some users who run RIVA for 24 hours a day, seven days a week.

Another vital aspect of RIVA highlighted by ARxIUM is the importance of strict sterile cleanliness, as the company cited the need for an automated system to fill that need. It believes that Stäubli’s TX-60L UL robot fits that bill.

ARxIUM has more than 50 TX-60L UL robots and controllers installed for RIVA compounding cells and has used RIVA machines to fill more than 8 million doses, according to a news release.

“ARxIUM takes great pride in its disciplined process of assessing a potential client’s business objectives and designing a solution that fits its specific needs and goal,” ARxIUM said in the news release. “The company applies this approach to help customers in every facet of the pharmacy market – including hospitals/health systems, government, long-term care and retail – to optimize operations and business through automated compounding, packaging and dispensing, production and workflow design, inventory control and storage and much more.”

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Moving toward the autonomous lab and what’s possible today
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE